Data gathered: November 5
Alternative Data for Cytek BioSciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 20 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 70,000 | Sign up | Sign up | Sign up |
| Employee Rating | 78 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 24 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 10 | Sign up | Sign up | Sign up |
| Facebook Followers | 741 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 110 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,188 | Sign up | Sign up | Sign up |
| Twitter Mentions | 41 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,540 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 399 | Sign up | Sign up | Sign up |
About Cytek BioSciences
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
| Price | $5.20 |
| Target Price | Sign up |
| Volume | 695,720 |
| Market Cap | $672M |
| Year Range | $4.69 - $9.15 |
| Dividend Yield | 0% |
| PE Ratio | 351.5 |
| Analyst Rating | 75% buy |
| Earnings Date | November 5 '24 |
| Industry | Medical Devices |
In the news
Warning: CTKB is at high risk of performing badlyOctober 27 - Seeking Alpha |
|
 |
The Manufacturers Life Insurance Company Has $357,000 Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)October 18 - ETF Daily News |
 |
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Up 5.4% in SeptemberOctober 17 - Biztoc.com |
|
Millennium Management LLC Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)October 12 - ETF Daily News |
 |
Cytek Biosciences (NASDAQ:CTKB) Trading 3.6% Higher - What's Next?October 9 - Biztoc.com |
 |
Renaissance Technologies LLC Makes New $1.31 Million Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB)October 6 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 47M | 21M | 25M | -10M | -7.6M | -0.080 |
| Q1 '24 | 45M | 22M | 23M | -6.2M | -7.7M | -0.050 |
| Q4 '23 | 58M | 25M | 33M | 5.5M | 5.4M | 0.040 |
| Q3 '23 | 48M | 21M | 27M | -6.5M | -2.7M | -0.050 |
| Q2 '23 | 50M | 22M | 28M | -4.4M | -5.2M | -0.030 |
Insider Transactions View All
| Yan Ming filed to sell 5,988,502 shares at $5.9. April 23 '24 |
| Yan Ming filed to sell 6,008,502 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,008,902 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,010,402 shares at $6.7. March 19 '24 |
| Jeanmonod Patrik filed to sell 93,400 shares at $9.5. December 27 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$84.72 0% | 63 |
 |
Edwards LifesciencesEW |
$66.47 0% | 43 |
 |
Intuitive SurgicalISRG |
$507.42 0% | 63 |
 |
MedtronicMDT |
$89.31 0% | 66 |
 |
StrykerSYK |
$366.9 0% | 66 |
Read more about Cytek BioSciences (CTKB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Cytek BioSciences?
The Market Cap of Cytek BioSciences is $672M.
What is Cytek BioSciences' PE Ratio?
As of today, Cytek BioSciences' PE (Price to Earnings) ratio is 351.5.
When does Cytek BioSciences report earnings?
Cytek BioSciences will report its next earnings on November 5 '24.
What is the current stock price of Cytek BioSciences?
Currently, the price of one share of Cytek BioSciences stock is $5.20.
How can I analyze the CTKB stock price chart for investment decisions?
The CTKB stock price chart above provides a comprehensive visual representation of Cytek BioSciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cytek BioSciences shares. Our platform offers an up-to-date CTKB stock price chart, along with technical data analysis and alternative data insights.
Does CTKB offer dividends to its shareholders?
As of our latest update, Cytek BioSciences (CTKB) does not offer dividends to its shareholders. Investors interested in Cytek BioSciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Cytek BioSciences?
Some of the similar stocks of Cytek BioSciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.